Your browser doesn't support javascript.
loading
Gammaglobulin for primary immunodeficiency: when should it be used? / Gamaglobulina para imunodeficiência primária: quando usar?
Roxo-Junior, Pérsio.
Affiliation
  • Roxo-Junior, Pérsio; University of São Paulo. Medical School. Ribeirão Preto. BR
Medicina (Ribeiräo Preto) ; 47(1): 5-9, jan.-mar. 2014.
Article in English | LILACS | ID: lil-714253
Responsible library: BR26.1
ABSTRACT
Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of thewell-known primary immunodeficiencies requiring gammaglobulin replacement therapy. On the other hand this therapy can be used for some diseases that do not belong to this group, like hyper IgM syndrome, immunodeficiency with thymoma and severe combined immunodeficiency. This therapy is a safe procedure and induces dramatic improvement in the clinical outcome of patients, reducing the risks of death and complications.
RESUMO
Anticorpos são componentes essenciais da resposta imunológica adaptativa e apresentam memória imunológica em longo prazo. Defeitos de anticorpos representam aproximadamente metade das imunodeficiências primárias conhecidas e requerem terapia de reposição de gamaglobulina. Por outro lado, esta modalidade terapêutica pode ser usada para algumas outras doenças que não pertencem a este grupo, como síndrome de hiper IgM, imunodeficiência com timoma e imunodeficiência combinada grave. Este tratamento é um procedimento seguro e acarreta em significativa melhora clínica dos pacientes, reduzindo os riscos de morte e complicações.
Subject(s)

Full text: Available Collection: International databases Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases Health problem: Target 3.3: End transmission of communicable diseases / AIDS Database: LILACS Main subject: Biological Therapy / Immunoglobulins / Acquired Immunodeficiency Syndrome / Infections Limits: Humans Language: English Journal: Medicina (Ribeiräo Preto) Journal subject: Medicine Year: 2014 Document type: Article Affiliation country: Brazil Institution/Affiliation country: University of São Paulo/BR
Full text: Available Collection: International databases Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases Health problem: Target 3.3: End transmission of communicable diseases / AIDS Database: LILACS Main subject: Biological Therapy / Immunoglobulins / Acquired Immunodeficiency Syndrome / Infections Limits: Humans Language: English Journal: Medicina (Ribeiräo Preto) Journal subject: Medicine Year: 2014 Document type: Article Affiliation country: Brazil Institution/Affiliation country: University of São Paulo/BR
...